Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report released on Sunday. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Stock Up 1.2 %

NASDAQ:STRM opened at $2.61 on Friday. Streamline Health Solutions has a 1 year low of $1.85 and a 1 year high of $9.75. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The stock has a market cap of $11.02 million, a price-to-earnings ratio of -0.53 and a beta of 1.64. The stock has a 50-day moving average price of $3.17 and a two-hundred day moving average price of $5.49.

Streamline Health Solutions (NASDAQ:STRM) last issued its quarterly earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The business had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.